Daniel J Drucker
@DanielJDrucker
A clinician scientist at LTRI @sinaihealth @uoft @uoftmedicine who studies peptide hormones, GLP-1, diabetes, obesity and the gut endocrine system 🇨🇦🇮🇱
03-05-2011 13:51:01
30,0K Tweets
28,9K Followers
1,1K Following
Based on studies in mice, the authors propose that an #IntermittentFasting IF 5:2 regimen is a promising intervention against NASH and subsequent liver cancer Cell Metabolism cell.com/cell-metabolis…